Reshma Shringarpure
Company: Akero Therapeutics
Job title: Vice President of Clinical Research
Seminars:
Normalization of Liver Fat Following Treatment with Efruxifermin & Relationship with Histologic & Metabolic Improvements 4:00 pm
• Learning about the six-fold higher probability of NASH resolution with liver fat normalization • Investigating the correlation between change in liver fat and decrease in markers of liver stress, injury, and restoration of metabolic health • Analyzing the consistent improvements in fibrosis as assessed by serum markers, imaging, and histology in NASH patients with…Read more
day: Day Two